OLMEXA 25 MT is used for effective management of hypertension and cardiovascular risk. It contains Olmesartan Medoxomil 20 mg + Metoprolol Succinate 25 mg, offering dual action for better blood pressure control. Olmesartan relaxes blood vessels by blocking angiotensin II, while Metoprolol reduces heart rate and cardiac workload. This combination helps maintain stable blood pressure, supports heart health, and is commonly prescribed for long-term cardiovascular protection.
